| Metric | Value (₹ Cr) |
|---|---|
| Revenue | 133.25 |
| Total Income | 141.41 |
| Expenditure | 112.02 |
| PBT | 29.39 |
| Net Profit | 21.82 |
| OPM | 23.53% |
| NPM | 15.43% |
| EPS | 3.86 |
Order Visibility Drives Momentum—Watch Execution Cadence & Margin Recovery
The ₹586 Cr BEL radar contract and ₹4,000 Cr orderbook set the bar for scale. Street expects steady 24% FY27 growth; Q2 will test whether margins bounce back after Q1's dip.
The Setup: Order-Backed Growth, But Execution Is the Frame
Data Patterns trades on two vectors: order book visibility (now ₹4,000+ Cr post-BEL) and execution cadence. Q2 FY27 will test both. The company delivered 17% YoY revenue growth in Q1 (₹116.0 Cr standalone) against FY27 full-year Street guidance of 24% growth to ~₹1,150 Cr. The ₹586 Cr BEL radar electronics contract (awarded Aug 21) dramatically extends the runway, but defence order realization is lumpy—the print will reveal how much of the order pipeline is flowing into H2 realizations.
What to Expect—Revenue and Margins
~₹110–125 Cr
Q1 was ₹116 Cr; Q2 typically inline or slightly higher; base case ~18% YoY growth
~35–38%
Q1 margin dipped to ~32% (vs historical 39–40%); normalization expected as mix improves
₹4,200+
BEL order, STAC acquisition integration, and H1 execution will reshape the composition
A strong print: Revenue tracks 20%+ YoY with EBITDA margin back to 38%+, signalling order execution is meeting internal pacing and mix normalizing. Order book guidance above ₹4,200 Cr. A weak print: Sequential revenue flat/down (suggesting execution slippage), margin stuck below 32%, or order book guidance disappointing—would signal BEL or other contracts facing delays or margin pressure.
On Track to Guidance?
The Street expects Data Patterns to deliver ~24% FY27 revenue growth (to ~₹1,150 Cr) and EPS of ₹59.80 (+22%). Q1's 17% growth is slightly behind the pace, but two factors soften the concern: (1) Defence order recognition is front-loaded in certain quarters; (2) The ₹586 Cr BEL award post-Q1 now sits in the H2 backlog. Management's Aug guidance for 25% growth and 40% EBITDA margins through FY27 expansion suggests confidence in H2 realizations. Q2 margin recovery will be the test of whether the Q1 dip was noise or signal.
What the Street Says
Since Last Quarter: Orders, Acquisition, and Board Governance
1 · BEL Radar Contract (Aug 21, 2026)
₹585.76 Cr procurement order for radar electronics from Bharat Electronics Limited. Transformational for revenue visibility, but realization likely H2–FY28; test execution pace and margin profile in each quarter.
2 · ST Advanced Composites Acquisition (Aug 25, 2026)
Completed acquisition of STAC for ₹10 Cr (~₹1.5 Cr equity + ₹8.5 Cr loan). Vertical integration play; accretive from FY27. No material earnings impact in Q2 but integration and synergy realization will be a H2 story.
3 · Q1 FY27 QIP Proceeds Utilization (July 30, 2026)
Monitoring agency (ICRA) confirmed QIP funds deployed into capacity expansion and working capital. On-plan utilization; follow the capex trajectory in management commentary.
4 · Dividend & AGM (July 31, 2026)
Board recommended ₹10 dividend for FY26 (paid post-AGM). Capital return signals cash strength and shareholder confidence.
The Close: What to Watch on Result Day
Data Patterns enters Q2 with two tailwinds (order backlog now ₹4,000+ Cr, BEL contract visibility) and one headwind (margin reset post-Q1 dip). The result will hinge on (1) execution—revenue realization cadence vs the BEL and existing order backlog, (2) margin recovery—EBITDA % normalizing back to 38%+ (or signal of mix/pricing pressure), and (3) order book composition—which contracts are flowing through H2, BEL pacing, and any new wins. Management commentary on full-year execution pace, especially defence customer capex cycles and STAC integration, will frame the FY27 guide. Street will monitor whether the company can sustain 24% growth and 40% margins through expansion; execution risk is real on defence orders, but the order book has never been stronger.
₹133 Crore Revenue, ₹2,700 Crore Order Book — Why the Math Doesn't Add Up Yet
Data Patterns reported a 57% YoY revenue collapse to ₹133 Crore, yet management reaffirmed 20–25% FY27 growth guidance. The call reveals why: execution delays on government approvals have stranded a strong order book. The question is whether this is temporary lumpiness or structural risk.
₹133.3 Cr
–56.7% YoY from ₹306 Cr
₹3.6+ Cr
₹2,698 Cr + ₹956 Cr awaiting formal receipt
₹21.8 Cr
–55.6% YoY; NPM 15.4%
>₹500 Cr
Supports ₹150–200 Cr capex plan
The core tension: visibility without execution
The quarter's headline is unambiguous: revenue ₹133.3 Crore, down 57% year-on-year from ₹306 Crore in Q2 FY26. PAT fell in tandem to ₹21.8 Crore (–55.6% YoY), with operating margin at 23.5%, below the 35–40% EBITDA range management reaffirmed on this call. But alongside that collapse sits an order book of ₹2,698 Crore (as of 30-Sep-2026), plus another ₹956 Crore in negotiated contracts awaiting formal government receipt. That's ₹3.6+ Crore of visibility—enough to cover 27 quarters at the current revenue run rate. The gap between that order book and this quarter's ₹133 Crore execution is the real story.
Management's claims: what holds up
Order inflows in H1 FY27 reached ₹1,046 Cr, including ₹929 Cr in Q2
Confirmed. Q2 inflows were strong, dominated by defence radar and EW orders. Signals growing customer confidence.
Supported
Reaffirming 20–25% FY27 revenue growth and 35–40% EBITDA margins
H1 YoY revenue down 56.7% (₹133 Cr Q2 + ₹116 Cr Q1). To hit 20% FY27 growth, H2 must grow ~38% YoY. Achievable only if large orders convert immediately. OPM 23.5% contradicts margin guidance.
Overstated
Order book ₹2,698 Cr provides healthy visibility
Order book is real, but ₹956 Cr (26% of the total) remains negotiated and awaiting formal government receipt. CFO stated delays are due to 'internal processes… different approval processes.' Execution timing uncertain.
Partial
No cancellation risk on government orders
Management confident—all are Central Govt funded tenders. But delays evident (Q2 inflows haven't yet translated to Q2 revenue). Timing risk is real, even if cancellation risk is low.
Supported (but timing risk high)
What changed on this call
Order inflow acceleration: H1 FY27 ₹1,046 Cr vs. ₹167 Cr in Q1 FY26 (comparable quarter)—4x faster.
ST Advanced Composites 100% acquisition (Sep 2026) to strengthen composite design and manufacturing for radars.
Revenue execution timing slippage: Q2 FY27 ₹133 Cr vs. ₹306 Cr Q2 FY26, largest miss in at least two years.
Capex plan expanded: ₹150–200 Cr baseline over 2 years, plus additional investment (>₹150 Cr) planned post-Board approval for satellite and new manufacturing infrastructure.
New product roadmap visible but timeline risk: satellite launch 3–4 years away; counter-drone demo-ready in 1–2 months; BrahMos seeker still in qualification; Tejas Mk2 under negotiation.
The bull-bear ledger
Order book ₹3.6+ Crore (including negotiated) provides tangible multi-year visibility in a defence hardware business.
Defence indigenization tailwind (Make in India, Make II) structural—DRDO and MoD emphasizing domestic vendors over imports.
Cash position >₹500 Cr supports capex intensity (₹150–200 Cr over 2 years) without external financing.
Engineering capability expanding (1,100+ engineers, active recruitment, ISRO partnership for satellite program).
Q2 revenue collapse (–57% YoY) contradicts FY27 guidance (20–25% growth); requires unlikely 38% H2 ramp.
Operating margin 23.5%, well below 35–40% guidance range; heavy R&D and capex drag near-term profitability.
Government approval bottleneck evident: ₹956 Cr negotiated orders stuck in 'internal processes'; CFO acknowledged delays.
New products are 3–4 years out (satellite) or early-stage (counter-drone, Tejas Mk2); near-term revenue upside limited.
Customer concentration on DRDO, PSUs (Bharat Electronics, HAL); government budget cycles and approval processes uncontrollable.
Export market nascent; PAR radars in progress (delivery Q1 FY28 expected) but revenue timing uncertain.
Risks, ranked by how much they should concern a holder
Order execution timing slippage
High₹956 Cr negotiated orders are stuck waiting for government internal approvals. CFO explicitly framed this as endemic ('different approval processes'). Q2 order inflows (₹929 Cr) haven't yet converted to revenue. If delays extend into Q3/Q4, FY27 guidance (20–25% growth) becomes unachievable.
FY27 growth guidance at risk
HighH1 YoY revenue declined 56.7%. To achieve 20% FY27 growth, H2 must grow ~38% YoY—a dramatic ramp from 27% underperformance in H1. Analysts pressed management on feasibility; responses deflected to 'lumpy business' without owning execution gaps.
New product revenue still 3–4 years out
HighSatellite program, anti-drones, Tejas Mk2, BrahMos seeker are all early-stage or in qualification. None contribute to revenue in the next 12–18 months. Near-term growth depends entirely on order-book conversion from existing government contracts.
Government customer concentration and approval bottleneck
MediumDRDO, HAL, Bharat Electronics dominate the customer base. Budget cycles, tender timelines, and internal approval processes are uncontrollable. Private sector expansion is nascent. Export market (PAR radars) is early-stage.
Capex intensity relative to cash buffer
Medium₹150–200 Cr capex over 2 years on ~₹500 Cr cash leaves limited margin for operational shocks. Additional investment (>₹150 Cr) planned post-Board approval further tightens liquidity. Working capital cycle elongating due to government payment delays.
Margin compression from R&D and facility capex
MediumOPM 23.5% is 11–16pp below the 35–40% EBITDA guidance. Heavy R&D on satellite, counter-drone, and new facilities will continue to drag margins in the near term. No path to guidance-level margins visible in near-term.
How the street is positioned
The stock closed at ₹4,190 on result day (16-Nov-2026), trading in a neutral trend. At this price, it sits 16.18% below its all-time high of ₹4,999, but +96.62% off the 52-week low. RSI at 54.4 signals no overbought or oversold condition—the market is still forming a consensus. Institutional positioning has shifted: FII trimmed from 12.50% (Q1 FY27) to 11.34% (Q2 FY27), a drop of 1.16pp. DII added 1.03pp to 13.01%. The divergence is telling: foreign investors are stepping back ahead of the guidance-vs-execution debate; domestic institutions are buying selectively at lower levels. Recent bulk activity shows Graviton Research Capital selling ~4 lakh shares at ₹3,943 and buying ~4 lakh at ₹3,944 on 9-Nov-2026—opportunistic trading near the 52-week moving average, not a structural vote of confidence. Volume is increasing, but price hasn't broken through previous resistance. The market's own verdict: wait for clarity on H2 order execution before committing fresh capital.
The debate
What to watch next
1 · Negotiated order closure timeline (expected 1–2 months)
Management guided that ₹956 Cr in negotiated orders should close formally by Nov-Dec 2026. This is the binary catalyst. If closures slip beyond that window, guidance miss risk rises sharply.
2 · Q3 FY27 revenue run-rate and order-to-execution conversion
By Q3 earnings (expected Feb 2027), the street will see whether H2 acceleration is real. A ₹160–180 Cr Q3 run-rate (vs. ₹133 Cr Q2) would signal order-to-revenue conversion is normalizing. Below ₹150 Cr suggests execution delays persist.
3 · Operating margin trend and capex impact
OPM at 23.5% is below guidance. Watch whether margins recover toward 30%+ as order delivery accelerates, or if new facility capex and R&D spending (satellite, counter-drones) continue to compress profitability in Q3–Q4.
4 · FII/DII flows and institutional consensus
FII trimmed 1.16pp this quarter while DII added. If FII continues to exit heading into Q3 earnings (before H2 guidance clarity), that's a risk signal. DII adds suggest some domestic institutions see value at current levels, but they may be early.
The number to track
H2 FY27 order-to-revenue conversion rate. If Data Patterns can convert ₹800+ Crore of its ₹1.7 Crore order book into H2 (Jan–Mar 2027) revenue, the ₹20–25% FY27 growth guidance holds and the stock has room to re-rate above ₹4,500. If H2 conversion stays below ₹150 Cr per month (implying ₹300 Cr or less for the half), the year will miss guidance materially, and the stock will drift back toward ₹3,500–₹3,800 as the market reprices execution risk. The order book is real—the question is when it becomes revenue.
Data Patterns is not a broken company. The order book is visible, the defence indigenization tailwind is structural, and the engineering talent is real. But Q2's 57% revenue collapse and the stranded ₹956 Crore in negotiated orders expose a hard truth: this is a government-paced business, and government approvals are not on management's timeline. Reaffirming 20–25% FY27 growth while reporting a 56.7% H1 YoY decline is a bet on compressed execution in H2—achievable but risky. For holders, this is a 'prove it next quarter' moment. For new buyers, waiting for Q3 earnings clarity (Feb 2027) after seeing whether the negotiated orders close and H2 execution accelerates is the prudent path. The stock's retreat from ATH is fair. The real price discovery happens when order-to-revenue conversion becomes visible.
Order book strong, but execution delays and 57% YoY revenue collapse raise near-term concerns
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Reaffirmed 20–25% FY27 growth despite Q1–Q2 YoY decline of 56.7%. Frame is 'lumpy business'—defensible, but execution risk is high.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Order book visibility is real (₹2.7 Cr) and long-term TAM is genuine, but Q2's 57% revenue collapse and manifest execution delays on government contracts expose the gap between stated FY27 guidance (20–25% growth) and near-term delivery. Management has ₹150–200 Cr capex plans against ~₹500 Cr cash, leaving little margin for further shocks.
₹133.3 Cr
Revenue · −56.7% YoY₹21.8 Cr
Reported PAT · −55.6% YoYFlat
Margins · vs guidance: OverstatedDid the claims hold up?
Order inflows during H1 FY27 ₹1,046 Cr including ₹929 Cr in Q2
METQ2 delivered revenue only ₹133.3 Cr, suggesting massive order-to-execution lag
Remaining confident about 20–25% FY27 revenue growth
OVERSTATEDH1 YoY revenue down 56.7%; H2 would need ~38% growth to achieve 20% FY27 target — achievable only if large orders execute
Order book ₹2,698 Cr as of 30-Sep-2026 provides healthy visibility
PartialOrder book visible but ₹956 Cr still negotiated/awaiting formal receipt; execution risk high due to stated delays in approvals
EBITDA margins 35–40% maintained
UnverifiedOPM 23.5%, NPM 15.4% — no EBITDA breakdown given, but operating margin below guidance range
Earnings quality
What changed since the last call
Order inflow acceleration
UpgradeH1 FY27 ₹1,046 Cr inflows vs ₹167 Cr in Q1 FY26 (comparable quarter). Confidence in customer pipeline cited.
Revenue execution timing slippage
DowngradeQ2 FY27 ₹133.3 Cr vs ₹306 Cr Q2 FY26 (-56.7%). Management notes large FY26 Q2 contract executed; current backlog requires H2 ramp to meet FY27 guidance.
Capex guidance reaffirmed
Neutral₹150–200 Cr over 2 years for capacity & R&D. No change to prior call, but intensity rising (new facility, satellite infrastructure).
Product portfolio expansion
NewST Advanced Composites 100% acquisition (Sep 2026) adds composite design capability for radars; satellite development initiated in-house.
The Q&A
Analysts pressed hard on revenue execution gap. Abhijeet Singh (Systematix) asked if revenue guidance at risk; management deflected to 'program-based business' and 'next 1–2 months' order closures. Dipen Vakil (PhillipCapital) asked on HAL pipeline—management vague on Tejas Mk2 (under negotiation, not in projections). Ayush Sharma (Nirmal Bang) asked if 50% of ₹1.7 Cr order book executable by FY27—management agreed this is working estimate but qualified with timing risk on government approvals. Overall tone was managed but defensive.
Negotiated order delays — Abhijeet Singh, Systematix
PartialNo cancellation risk. Central Govt tenders, funded programs. Delays due to internal approval processes (reference/compliance). Expected closure 1–2 months.
FY27 growth feasibility — Abhijeet Singh, Systematix
DodgedYes. This is a quarterly heavy business; we aim for quarterly variation. Orders in hand; will accelerate in H2.
Space segment strategy — Amit Dixit, Goldman Sachs
AnsweredHeavily invested. Counter-drone 1–2 months from demo-ready. Space (satellite) will launch in 3–4 years. Building in-house; not outsourcing.
Export market opportunity — Amit Dixit, Goldman Sachs
PartialPAR (passive radar) for Europe delivery expected Q1 FY28. Co-investing in radars with UK partner. Civil aviation & avionics products also in target. Expect 'large revenue post-qualification' but timeline uncertain.
Space segment timing — Garvit Goyal, Serene Alpha
DodgedMk2 is not anti-drone. Tejas Mk2 under negotiation with HAL (should close in next couple of months). Not part of projections yet. Many other products (pod, AMCA) can be positioned in Mk2 also.
5-year order scaling potential — Sagar Gandhi, Invesco Mutual Fund
PartialProducts we design can scale 5x the current numbers. Risk is in development—we're reducing via building blocks model. India's 0 base in defence products means no precedent. Scaling is achievable if we build competencies.
Capex spend on capabilities — Keyurkumar Vadaliya, Niveshaay
PartialBuilding blocks are customizable for any product/market. ₹150 Cr is multi-purpose capacity & facility. Additional investment (>₹150 Cr) also planned for infrastructure & satellite manufacturing. Board approval pending.
BrahMos seeker manufacturing — Akshay Jogani, Xponent Tribe
AnsweredSeeker undergoing qualification test. Only post-qualification will production orders come. Expect production orders in next few months; manufacturing line setup underway.
Order execution sequencing — Neil Ostwal, PGIM India
AnsweredSome execute this year. Some next year & year after. Scheduled delivery timelines given by customer; we will confirm. 20–25% growth plan assumes execution over 2 quarters to achieve guidance.
Order book execution expectation — Ayush Sharma, Nirmal Bang
AnsweredSomewhere around 50% in next 2 quarters to achieve guidance. Depends on customer delivery schedules & approvals. Some delays in existing programs; components already ordered; prudent in timelines.
Counter-drone tender participation — Abhijeet Singh, Systematix
PartialHawk—still delays in software integration but hardware ready. Sukhoi-30 pods self-protection jammer progressing well. Air Force happy. Expect integration in next months. Counter-drone tenders—already participating on Make II programs; product complete.
Guidance
FY27 revenue growth 20–25%
MediumReaffirmed despite H1 YoY decline of 56.7%. Contingent on H2 acceleration & order-to-revenue conversion from ₹1.7 Cr order book.
EBITDA margins 35–40%
MediumOPM 23.5%, NPM 15.4% reported; EBITDA breakdown not disclosed. Heavy capex & R&D drag margins in near-term.
₹150–200 Cr capex over 2 years
MediumSplit between capability building, facilities, satellite manufacturing infrastructure. Additional investment (>₹150 Cr) also planned post-Board approval.
Risks the call surfaced
Order execution timing
High₹956 Cr negotiated orders stuck in government approval processes. CFO: 'The delay is on account of internal processes... different approval processes.' Q2 order inflows (₹929 Cr) have not yet converted to revenue.
FY27 guidance at risk
HighH1 FY27 YoY revenue decline 56.7% (₹133.3 Cr Q2, ₹116 Cr Q1). To achieve 20% FY27 growth, H2 must grow ~38% YoY. Achievable only if large orders execute.
New product development risk
HighSatellite, anti-drones, Tejas Mk2, BrahMos seeker all in early stages. Satellite 3–4 years away; counter-drone tenders uncertain; BrahMos seeker still in qualification test. No near-term revenue.
Customer concentration & market dependency
MediumDominant customer base is DRDO, PSU (Bharat Electronics, HAL). Government budget allocation, approval delays, tender process cycles dictate order flow. Private sector expansion nascent.
Capex intensity & liquidity squeeze
Medium₹150–200 Cr capex over 2 years planned; cash balance >₹500 Cr. Additional investment (>₹150 Cr) also discussed post-Board approval. If new orders don't convert to cash, liquidity could tighten.
Management
Score 6/10. Detailed on product roadmap & strategic vision but evasive on sensitive export/space programs. Transparent on order book & cash, but minimizes execution risk. Track record mixed: delivered large FY26 Q2 contract but missed near-term guidance in H1 FY27 (56.7% YoY decline). Order conversion bottleneck evident despite healthy pipeline.
1 · Nov 2026 – Feb 2027
₹956 Cr negotiated orders expected to close for formal receipt
2 · H2 FY27 (Jan–Mar 2027)
Program deliveries expected to accelerate; counter-drone tender bids and Make II participations
3 · FY28
BrahMos seeker production orders post-qualification; PAR radar exports expected Q1 FY28 delivery
Management has ₹150–200 Cr capex plans against ~₹500 Cr cash, leaving little margin for further shocks.